C
Exchange
—
Entity type
operating
Fiscal year end
Dec 31
Headquarters
DE
Recent Filings
- 411.2 KBCELGENE CORP /DE/Jul 13, 6:27 PM ET·0001104659-20-083172
- 47.0 KBCELGENE CORP /DE/Jul 6, 5:24 PM ET·0001104659-20-081337
- 8-K269.2 KBCELGENE CORP /DE/Nov 22, 5:15 PM ET·0001104659-19-066707
- 8-K443.7 KBCELGENE CORP /DE/Nov 20, 5:25 PM ET·0001104659-19-065939
- 412.9 KBCELGENE CORP /DE/Nov 14, 4:06 PM ET·0001104659-19-064171
- 10-Q16.6 MBCELGENE CORP /DE/Oct 31, 4:03 PM ET·0000816284-19-000046
- 8-K738.9 KBCELGENE CORP /DE/Oct 31, 7:37 AM ET·0001104659-19-058070
- 8-K1.2 MBCELGENE CORP /DE/Aug 26, 7:30 AM ET·0001144204-19-041582
- 10-Q16.5 MBCELGENE CORP /DE/Jul 30, 4:10 PM ET·0000816284-19-000039
- 8-K708.0 KBCELGENE CORP /DE/Jul 30, 7:42 AM ET·0001104659-19-042485
Insiders
10- AHMED NADIMPRES., HEMATOLOGY AND ONCOLOGY
- Alles Mark JChief Commercial Officer
- BARER SOL JDirector, Chief Executive Officer
- BARKER RICHARD WDirector
- Biller JonathanEVP and General Counsel
- Bishop Hans EdgarDirector
- BONNEY MICHAEL WDirector
- BOWMAN JACK LDirector
- BROUWER AARTPresident International
- Burton GrahamSee Remarks
Tickers
No tickers on record
Addresses
business
86 MORRIS AVENUE
SUMMIT, NJ, 07901
mailing
86 MORRIS AVENUE
SUMMIT, NJ, 07901